Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication

scientific article (publication date: 2013)

Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...881783O
P356DOI10.1371/JOURNAL.PONE.0081783
P932PMC publication ID3859510
P698PubMed publication ID24349127
P5875ResearchGate publication ID259354892

P50authorJohan NeytsQ29460378
Jan PaeshuyseQ29460392
Philip MeulemanQ42716541
Christophe PannecouqueQ50551511
P2093author name stringVan Cuong Pham
Van Hung Nguyen
Wim Dehaen
Susan Obeid
Thanh Nguyen Le
Jo Alen
P2860cites workProduction of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cellsQ27473106
The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease InhibitorsQ27485895
Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomersQ33815957
Natural products as promising drug candidates for the treatment of hepatitis B and C.Q34015041
Ancient Chinese methods are remarkably effective for the preparation of artemisinin-rich extracts of Qing Hao with potent antimalarial activity.Q34106578
Analysis of combinations of antiviral drugs and design of effective multidrug therapiesQ34231507
The activity of the HIV-1 IRES is stimulated by oxidative stress and controlled by a negative regulatory elementQ34559697
Artemisinin: mechanisms of action, resistance and toxicityQ34999485
Clinical trial results of peginterferons in combination with ribavirinQ35204884
The global pipeline of new medicines for the control and elimination of malariaQ36320249
The antiviral activities of artemisinin and artesunate.Q37242654
Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress inductionQ37365121
Antiviral therapy for hepatitis C virus: beyond the standard of careQ37945201
Resistance to anti-HCV protease inhibitors.Q37996228
Emerging drugs for malariaQ38027179
The science of direct-acting antiviral and host-targeted agent therapyQ38063181
Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicalsQ39014626
Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cellsQ39660185
Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB.Q39770321
Substituted imidazopyridines as potent inhibitors of HCV replicationQ39869987
Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteinsQ40094231
Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cellsQ40151461
Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisininQ40250273
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.Q40381469
Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.Q40473957
Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin.Q40557036
Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malariaQ40636345
Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malariaQ41258804
The reaction of artemisinins with hemoglobin: a unified pictureQ42166274
We still need artesunate monotherapyQ42374811
Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibioticsQ42744862
The role of triple therapy in HCV genotype 1-experienced patientsQ43032735
A topological study of the decomposition of 6,7,8-trioxabicyclo[3.2.2]nonane induced by Fe(II): modeling the artemisinin reaction with hemeQ43211874
Artesunate dosing in severe falciparum malariaQ43228042
Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses.Q43971464
Negative regulation of hepatitis B virus gene expression and replication by oxidative stressQ45779254
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantationQ46639393
Malaria-infected mice are cured by oral administration of new artemisinin derivativesQ46783289
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.Q46834246
Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technology.Q47980398
Functionalisation of artemisinin and its ring-contracted derivativesQ81241127
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectHepatitis C virusQ708693
artemisininQ426921
P304page(s)e81783
P577publication date2013-01-01
P1433published inPLOS OneQ564954
P1476titleArtemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication
P478volume8

Reverse relations

cites work (P2860)
Q96231357Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?
Q42207865Mangosteen xanthones suppress hepatitis C virus genome replication
Q47664127Peroxides with Anthelmintic, Antiprotozoal, Fungicidal and Antiviral Bioactivity: Properties, Synthesis and Reactions.
Q91584126The Transcription Factor Aabzip9 Positively Regulates the Biosynthesis of Artemisinin in Artemisia annua
Q92633499The Use of Antimalarial Drugs against Viral Infection

Search more.